We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.12%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$556B
AUM Growth
+$22.5B
Cap. Flow
-$5B
Cap. Flow %
-0.9%
Top 10 Hldgs %
17.58%
Holding
2,638
New
69
Increased
1,185
Reduced
969
Closed
83

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.8B
2
TSLA icon
Tesla
TSLA
+$1.74B
3
NXPI icon
NXP Semiconductors
NXPI
+$1.24B
4
DHR icon
Danaher
DHR
+$1.21B
5
BKNG icon
Booking.com
BKNG
+$1.09B

Sector Composition

Rank Sector Weight
1 Healthcare 17.78%
2 Financials 16.36%
3 Consumer Discretionary 14.69%
4 Technology 14.23%
5 Industrials 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AET
26
DELISTED
Aetna Inc
AET
$3.28B 0.59%
21,597,161
+223,488
+1% +$31.6M
AAL icon
27
American Airlines Group
AAL
$10.6B
$3.2B 0.57%
63,502,744
+10,065,773
+19% +$468M
VRTX icon
28
Vertex Pharmaceuticals
VRTX
$126B
$3.17B 0.57%
24,583,212
+1,604,569
+7% +$193M
SYK icon
29
Stryker
SYK
$130B
$3.13B 0.56%
22,529,456
+2,698,993
+14% +$370M
HD icon
30
Home Depot
HD
$355B
$3.11B 0.56%
20,255,018
-1,877,327
-8% -$288M
JNJ icon
31
Johnson & Johnson
JNJ
$625B
$2.87B 0.52%
21,671,106
-249,303
-1% -$31.8M
STT icon
32
State Street
STT
$50.7B
$2.84B 0.51%
31,690,745
-3,194,036
-9% -$266M
MRSH
33
Marsh
MRSH
$91.5B
$2.84B 0.51%
36,397,834
-4,549,415
-11% -$344M
HUM icon
34
Humana
HUM
$46.2B
$2.81B 0.51%
11,693,573
-661,287
-5% -$150M
ALXN
35
DELISTED
Alexion Pharmaceuticals
ALXN
$2.78B 0.5%
22,818,855
+3,533,117
+18% +$411M
PCG icon
36
PG&E
PCG
$38.5B
$2.75B 0.49%
41,374,997
-4,322,036
-9% -$291M
C icon
37
Citigroup
C
$226B
$2.72B 0.49%
40,657,851
+7,054,296
+21% +$433M
CI icon
38
Cigna
CI
$74.6B
$2.67B 0.48%
15,937,314
+1,654,367
+12% +$266M
INTU icon
39
Intuit
INTU
$89B
$2.66B 0.48%
20,012,460
+7,186,122
+56% +$932M
ORLY icon
40
O'Reilly Automotive
ORLY
$76.3B
$2.66B 0.48%
182,120,850
+21,651,555
+13% +$354M
AMTD
41
DELISTED
TD Ameritrade Holding Corp
AMTD
$2.65B 0.48%
61,638,146
+3,234,676
+6% +$126M
ICE icon
42
Intercontinental Exchange
ICE
$84.4B
$2.62B 0.47%
39,703,525
-1,906,507
-5% -$117M
ELV icon
43
Elevance Health
ELV
$85.5B
$2.55B 0.46%
13,546,421
+460,630
+4% +$82.8M
XOM icon
44
ExxonMobil
XOM
$634B
$2.53B 0.46%
31,345,822
-210,869
-0.7% -$17.3M
BIIB icon
45
Biogen
BIIB
$30.7B
$2.43B 0.44%
8,948,782
+830,591
+10% +$220M
BNY
46
Bank of New York Mellon
BNY
$107B
$2.41B 0.43%
47,301,939
-6,974,614
-13% -$334M
EA
47
DELISTED
Electronic Arts
EA
$2.4B 0.43%
22,660,101
+3,747,033
+20% +$386M
JCI icon
48
Johnson Controls International
JCI
$92.2B
$2.29B 0.41%
52,798,255
+2,503,131
+5% +$105M
CMCSA icon
49
Comcast
CMCSA
$90B
$2.29B 0.41%
58,781,498
-7,629,962
-11% -$301M
RHT
50
DELISTED
Red Hat Inc
RHT
$2.27B 0.41%
23,742,458
-2,894,244
-11% -$258M

Similar funds

T. Rowe Price Associates's Q2 2017 Portfolio in Review

As of Q2 2017, T. Rowe Price Associates held 2,638 positions worth $556B, up 4.2% from $534B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

T. Rowe Price Associates's Q2 2017 filing shows 69 new, 1,185 increased, 969 reduced and 83 closed positions. Its largest new stake was Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6: 15,513,011 shares worth $844M. The largest sale was Amazon, an estimated $1.8B.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2017 buy was Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6: 15,513,011 shares worth $844M.
  • T. Rowe Price Associates added most to Becton Dickinson in Q2 2017, an estimated $2.34B increase.
  • T. Rowe Price Associates's biggest Q2 2017 reduction was Amazon, cutting an estimated $1.8B.
  • T. Rowe Price Associates fully exited Yahoo Inc in Q2 2017, selling an estimated $362M.
  • T. Rowe Price Associates's ten largest holdings make up 18% of its $556B portfolio in Q2 2017.
  • T. Rowe Price Associates opened 69 new positions and closed 83 in Q2 2017.
  • T. Rowe Price Associates's portfolio value rose 4.2% quarter-over-quarter to $556B.

Based on T. Rowe Price Associates's 13F filing for Q2 2017, filed 14 Aug 2017.